{
    "nctId": "NCT02115607",
    "briefTitle": "Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy",
    "officialTitle": "Quantitative Subharmonic Breast Imaging: Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 17,
    "primaryOutcomeMeasure": "Subharmonic Aided Pressure Estimation (SHAPE) After Treatment for Complete Responders",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Females\n* Be diagnosed with T1 or greater LABC, any N and M0.\n* Be scheduled for neoadjuvant chemotherapy\n* Be at least 21 years of age.\n* Be medically stable.\n* If a female of child-bearing potential, must have a negative pregnancy test.\n* Have signed Informed Consent to participate in the study.\n\nExclusion Criteria:\n\n* Males\n* Females who are pregnant or nursing.\n* Patients with other primary cancers requiring systemic treatment.\n* Patients with any metastatic disease.\n* Patients undergoing neoadjuvant endocrine therapy.\n* Patients with known hypersensitivity or allergy to any component of Definity.\n* Patients with cardiac shunts or congenital heart defects.\n* Patients with unstable cardiopulmonary conditions or respiratory distress syndrome.\n* Patients with uncontrollable emphysema, pulmonary vasculitis, pulmonary hypertension or a history of pulmonary emboli.\n* Patients who have received any contrast medium (X-ray, MRI, CT or US) in the 24 hours prior to the research US exam.",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}